New asthma and COPD treatment, benralizumab, cuts need for further treatment by 30% compared to steroids.

Scientists have discovered a new treatment for asthma and COPD, called benralizumab, which reduces the need for further treatment by 30% compared to steroid tablets. Administered as an injection, benralizumab targets specific white blood cells to reduce lung inflammation. The treatment could potentially be given at home or in a doctor's office, reducing hospital visits and the risk of steroid side effects like diabetes and osteoporosis. This breakthrough marks the first new asthma treatment in 50 years.

November 28, 2024
62 Articles

Further Reading